Publikationen, an denen er mitarbeitet Yolanda Diebold Luque (10)

2018

  1. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation

    International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30

2017

  1. Designing lipid nanoparticles for topical ocular drug delivery

    International Journal of Pharmaceutics, Vol. 532, Núm. 1, pp. 204-217

2014

  1. Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing

    International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 12-20

2013

  1. A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model

    Gene Therapy, Vol. 20, Núm. 5, pp. 467-477

2011

  1. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles

    Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788

  2. Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells

    Molecular Vision, Vol. 17, pp. 279-290

2010

  1. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles

    Cornea, Vol. 29, Núm. 5, pp. 550-558

2008

  1. Chitosan-Based Colloidal Systems as Promising Topical Drug Carriers for Ocular Surface Disorders

    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS

2005

  1. Erratum: Chitosan Nanoparticles as New Ocular Drug Delivery Systems: In Vitro Stability, in Vivo Fate, and Cellular Toxicity (Pharmaceutical Research (2004) 21 (803-810))

    Pharmaceutical Research

2004

  1. Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity

    Pharmaceutical Research, Vol. 21, Núm. 5, pp. 803-810